VMD vs. ANAB
VMD (Viemed Healthcare Inc) and ANAB (AnaptysBio, Inc.) are both stocks. Both are in the Healthcare sector — VMD in Medical Devices, ANAB in Biotechnology. Over the past 5 years, VMD returned 11.57%/yr vs 30.82%/yr for ANAB. At a 0.18 correlation, their price movements are largely independent.
Performance
VMD vs. ANAB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VMD achieves a 65.68% return, which is significantly lower than ANAB's 105.41% return.
VMD
- 1D
- 0.41%
- 1M
- 17.80%
- 6M
- 70.03%
- YTD
- 65.68%
- 1Y
- 82.64%
- 3Y*
- 10.19%
- 5Y*
- 11.57%
- 10Y*
- —
ANAB
- 1D
- -0.30%
- 1M
- 18.41%
- 6M
- 122.93%
- YTD
- 105.41%
- 1Y
- 280.10%
- 3Y*
- 70.76%
- 5Y*
- 30.82%
- 10Y*
- —
VMD vs. ANAB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
VMD Viemed Healthcare Inc | 65.68% | -7.36% | 2.17% | 3.84% | 44.83% | -32.73% | 25.16% | 63.16% | 122.18% |
ANAB AnaptysBio, Inc. | 105.41% | 266.16% | -38.19% | -30.88% | -10.82% | 61.63% | 32.31% | -74.53% | -36.83% |
Correlation
The correlation between VMD and ANAB is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jan 4, 2018 | 0.18 |
The correlation between VMD and ANAB shifts across timeframes, from 0.10 (1 year) to 0.22 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
VMD:
$471.93M
ANAB:
$2.86B
VMD:
$0.37
ANAB:
-$0.90
VMD:
1.73
ANAB:
8.48
VMD:
3.46
ANAB:
149.43
VMD:
$286.57M
ANAB:
$232.39M
VMD:
$163.52M
ANAB:
$245.59M
VMD:
$46.09M
ANAB:
$52.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VMD vs. ANAB — Risk / Return Rank
VMD
ANAB
VMD vs. ANAB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Viemed Healthcare Inc (VMD) and AnaptysBio, Inc. (ANAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VMD | ANAB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.08 | ||
| Sortino ratioReturn per unit of downside risk | -1.63 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.54 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | 4.84 | 10.08 | -5.24 |
| Martin ratioReturn relative to average drawdown | 12.04 | 23.52 | -11.48 |
Loading charts...
Drawdowns
VMD vs. ANAB - Drawdown Comparison
The maximum VMD drawdown since its inception was -69.35%, smaller than the maximum ANAB drawdown of -92.08%. Use the drawdown chart below to compare losses from any high point for VMD and ANAB.
Loading charts...
Drawdown Indicators
| VMD | ANAB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.35% | -92.08% | +22.73% |
Max Drawdown (1Y)Largest decline over 1 year | -15.86% | -28.15% | +12.29% |
Max Drawdown (3Y)Largest decline over 3 years | -40.64% | -69.32% | +28.68% |
Max Drawdown (5Y)Largest decline over 5 years | -49.62% | -69.32% | +19.70% |
Current DrawdownCurrent decline from peak | 0.00% | -22.53% | +22.53% |
Average DrawdownAverage peak-to-trough decline | -29.22% | -64.35% | +35.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.62% | 12.04% | -5.42% |
Volatility
VMD vs. ANAB - Volatility Comparison
The current volatility for Viemed Healthcare Inc (VMD) is 7.18%, while AnaptysBio, Inc. (ANAB) has a volatility of 15.35%. This indicates that VMD experiences smaller price fluctuations and is considered to be less risky than ANAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VMD | ANAB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.18% | 15.35% | -8.17% |
Volatility (6M)Calculated over the trailing 6-month period | 29.60% | 46.82% | -17.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.33% | 69.54% | -31.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.95% | 65.56% | -24.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 57.60% | 75.31% | -17.71% |
Dividends
VMD vs. ANAB - Dividend Comparison
Neither VMD nor ANAB has paid dividends to shareholders.
Financials
VMD vs. ANAB - Financials Comparison
This section allows you to compare key financial metrics between Viemed Healthcare Inc and AnaptysBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
VMD and ANAB have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ANAB has higher volatility (15.35%) compared to VMD (7.18%). In terms of maximum drawdown, VMD dropped -69.35% vs ANAB's -92.08%.
ANAB currently has the higher Sharpe Ratio (4.08 vs 2.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VMD and ANAB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer